Eagle Asset Management Inc. cut its stake in The Advisory Board Co. (NASDAQ:ABCO) by 3.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 547,684 shares of the company’s stock after selling 19,195 shares during the period. Eagle Asset Management Inc. owned 1.36% of The Advisory Board worth $24,503,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. American Capital Management Inc. raised its stake in The Advisory Board by 6.6% in the second quarter. American Capital Management Inc. now owns 764,915 shares of the company’s stock valued at $27,070,000 after buying an additional 47,235 shares during the period. Stoneridge Investment Partners LLC bought a new position in The Advisory Board during the second quarter valued at approximately $2,287,000. Royal Bank of Canada increased its position in The Advisory Board by 6.0% in the first quarter. Royal Bank of Canada now owns 1,252,911 shares of the company’s stock valued at $40,406,000 after buying an additional 70,769 shares in the last quarter. Princeton Alpha Management LP bought a new position in The Advisory Board during the second quarter valued at approximately $236,000. Finally, Douglas Lane & Associates LLC increased its position in The Advisory Board by 31.6% in the second quarter. Douglas Lane & Associates LLC now owns 683,294 shares of the company’s stock valued at $24,182,000 after buying an additional 164,025 shares in the last quarter.

Institutional Ownership by Quarter for The Advisory Board (NASDAQ:ABCO)

The Advisory Board Co. (NASDAQ:ABCO) traded down 0.40% during mid-day trading on Monday, reaching $37.05. 82,733 shares of the company were exchanged. The stock has a 50-day moving average of $38.88 and a 200 day moving average of $38.64. The firm’s market capitalization is $1.49 billion. The Advisory Board Co. has a 1-year low of $18.87 and a 1-year high of $54.83.

The Advisory Board (NASDAQ:ABCO) last released its earnings results on Tuesday, November 1st. The company reported $0.28 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.40 by $0.12. The Advisory Board had a positive return on equity of 11.28% and a negative net margin of 5.77%. The firm had revenue of $200.50 million for the quarter, compared to analysts’ expectations of $203.35 million. During the same quarter in the previous year, the company posted $0.33 earnings per share. The firm’s quarterly revenue was up .0% on a year-over-year basis. Equities research analysts forecast that The Advisory Board Co. will post $1.83 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Eagle Asset Management Inc. Has $24,503,000 Stake in The Advisory Board Co. (ABCO)” was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this story can be read at https://www.thecerbatgem.com/2016/11/28/eagle-asset-management-inc-has-24503000-stake-in-the-advisory-board-co-abco.html.

Several research analysts recently commented on ABCO shares. Canaccord Genuity set a $50.00 price target on shares of The Advisory Board and gave the stock a “buy” rating in a research note on Wednesday, September 28th. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $50.00 price target on shares of The Advisory Board in a research note on Friday, September 16th. JPMorgan Chase & Co. started coverage on shares of The Advisory Board in a research note on Friday, October 28th. They issued a “buy” rating and a $45.00 price target on the stock. Cantor Fitzgerald set a $37.00 price target on shares of The Advisory Board and gave the stock a “hold” rating in a research note on Wednesday, November 2nd. Finally, Stifel Nicolaus reduced their price target on shares of The Advisory Board from $45.00 to $43.00 and set a “hold” rating on the stock in a research note on Wednesday, November 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $43.25.

In related news, insider Hoose Mary Van sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 22nd. The shares were sold at an average price of $36.98, for a total transaction of $73,960.00. Following the sale, the insider now directly owns 37,386 shares in the company, valued at $1,382,534.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Robert W. Musslewhite sold 5,500 shares of the company’s stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $43.09, for a total transaction of $236,995.00. The disclosure for this sale can be found here. Corporate insiders own 2.90% of the company’s stock.

About The Advisory Board

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Stock Ratings for The Advisory Board Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Co. and related stocks with our FREE daily email newsletter.